This 16-hour live course includes 9 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.

This 1-hour and 45-minute, on-demand session from the 2024 ASAM State of the Art Course discusses new approaches such as tele-harm reduction, brain stimulation, and more.

This 1-hour, 45-minute, on-demand session from the 2024 ASAM State of the Art Course discusses research and treatment approaches for common co-occurring disorders, such as HIV, hepatitis, infectious diseases, and stress and trauma.

This 75-minute on-demand session from the ASAM 55th Annual Conference addresses the fundamentals of PrEP and the unique challenges of PrEP among PWIDs.

This 88-hour on-demand conference includes 71 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.

This 75-minute on-demand session from the ASAM 55th Annual Conference addresses current recommendations for when, in whom and how to initiate treatment for HCV, comparing differences in treatment course, effectiveness & side effects between interferon-based & direct-acting antiviral therapies.

This 72.5 hour on-demand conference includes over 70 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.

This 75-minute on-demand session from the ASAM 54th Annual Conference addresses the common infections that patients with OUD present within a hospital setting and how to rapidly screen & diagnose OUD and initiate MOUD including injectable buprenorphine treatment while managing concurrent infections.

This 85.25-hour on-demand conference includes 69 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.

This 1-hour, journal article-based CME activity reviews a study of an educational intervention to increase HIV clinicians' naloxone prescribing. The intervention was designed to reduce overdose mortality among persons living with HIV, overdose being a major cause of preventable death in this population.